Application 075392
- Type
- ANDA
- Sponsor
- TEVA PARENTERAL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PROPOFOL | PROPOFOL | INJECTABLE;INJECTION | 10MG/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075392-001 | PROPOFOL | PROPOFOL | 10MG/ML | INJECTABLE / INJECTION | 2000-09-19 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A075392-001 | PROPOFOL | 10MG/ML | INJECTABLE / INJECTION | 2000-09-19 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A075392-001 | PROPOFOL | 10MG/ML | INJECTABLE / INJECTION | 2000-09-19 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A075392-001 | PROPOFOL | 10MG/ML | INJECTABLE / INJECTION | 2000-09-19 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A075392-001 | PROPOFOL | 10MG/ML | INJECTABLE / INJECTION | 2000-09-19 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Propofol | PROPOFOL | Civica, Inc | 9ba70032-40c2-41c5-9f99-d1f94032d3dc | 2026-09-18 | Warnings, Adverse reactions | Propofol PROPOFOL |
| PROPOFOL | PROPOFOL | Hospira, Inc. | 28d7ba00-f824-4e55-139a-03f509c099db | 2026-08-13 | Warnings, Adverse reactions | PROPOFOL PROPOFOL |
| propofol | PROPOFOL | Meitheal Pharmaceuticals Inc. | 548d5192-2e5e-4c1b-8f17-940b6e791ae5 | 2025-12-12 | Warnings, Adverse reactions | propofol PROPOFOL |
| Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | e3105799-a4b6-f3f4-e6e2-b2b29bbdb538 | 2025-09-11 | Warnings, Adverse reactions | PROPOFOL |
| Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | fee3bd4a-ade3-41fa-839a-48e9af69bcf4 | 2025-09-10 | Warnings, Adverse reactions | PROPOFOL |
| propofol | PROPOFOL | Sagent Pharmaceuticals | fa93f173-7858-4d88-860e-76ab97e65c2f | 2025-06-07 | Warnings, Adverse reactions | propofol PROPOFOL |
| PROPOFOL | PROPOFOL | Amneal Pharmaceuticals Private Limited | 6833edd6-ba8a-4b97-a872-ab253c64a903 | 2025-05-20 | Warnings, Adverse reactions | PROPOFOL PROPOFOL |
| Propofol | PROPOFOL | Avenacy, LLC | de351d5f-581d-4768-a4af-fbd8e5bce264 | 2025-04-30 | Warnings, Adverse reactions | Propofol PROPOFOL |
| Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | d1ae9e26-ffd6-43df-bbd6-869cdede6afe | 2025-04-21 | Warnings, Adverse reactions | PROPOFOL |
| Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | ee0c3437-614d-4631-a061-257f5f60c70b | 2025-02-20 | Warnings, Adverse reactions | PROPOFOL |
| PROPOFOL | PROPOFOL | HF Acquisition Co LLC, DBA HealthFirst | 99af9e0a-c268-84ca-e053-2a95a90a0a3e | 2025-01-08 | Warnings, Adverse reactions | PROPOFOL PROPOFOL |
| PROPOFOL | PROPOFOL | HF Acquisition Co LLC, DBA HealthFirst | 99c8438a-2b3c-796e-e053-2a95a90a0200 | 2025-01-08 | Warnings, Adverse reactions | PROPOFOL PROPOFOL |
| Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | 5cec3b97-5183-4a9d-accd-21e76c99d3dd | 2024-04-18 | Warnings, Adverse reactions | PROPOFOL |
| PROPOFOL | PROPOFOL | HF Acquisition Co LLC, DBA HealthFirst | 7b9599e0-5bad-742d-e053-2991aa0aee97 | 2022-12-09 | Warnings, Adverse reactions | PROPOFOL PROPOFOL |
| PROPOFOL | PROPOFOL | Hikma Pharmaceuticals USA Inc. | fdb77e13-f5a7-4c4a-9f8e-338b702239c8 | 2022-11-18 | Warnings, Adverse reactions | PROPOFOL PROPOFOL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.